Sci/Tech trending topics
6,040 results
AstraZeneca (LON: AZN)‘s stock had its “hold” rating reaffirmed by research analysts at Panmure Gordon in a report released on Wednesday, AnalystRatingsNetwork reports. They currently have a GBX 3,200 ($50.25) …mideasttime.com · 16 hours ago
utahpeoplespost.com
AstraZeneca (LON: AZN)‘s stock had its “market perform” rating reaffirmed by equities research analysts at Sanford C. Bernstein in a research note issued to investors on Tuesday, AnalystRatingsNetwork.com reports. They currently have a SEK 351.75 ...Zolmax News · 1 day ago
AstraZeneca (LON: AZN)‘s stock had its “market perform” rating reiterated by Sanford C. Bernstein in a research note issued on Tuesday, StockRatingsNetwork.com reports. They currently have a SEK 351.75 price target on the stock ...watchlistnews.com · 15 hours ago
AstraZeneca (LON: AZN)‘s stock had its “hold” rating reiterated by research analysts at Deutsche Bank in a report released on Wednesday, Analyst Ratings Network reports. They currently have a GBX 3,550 ($55.75) price target on the stock. Deutsche ...Daily Political · ByLatisha Jones · 16 hours ago
AstraZeneca (AZN) recently announced that MedImmune (the biologics research and development arm of AstraZeneca) has entered into an agreement with privately-held US-based company, NGM Biopharmaceuticals, Inc. for discovery, development and ...Investopedia · 1 day ago
LONDON -- Successful investors use a disciplined approach to picking stocks, and checklists can be a great way to make sure you've covered all the bases. In this series, I'm subjecting companies to scrutiny under five …INSIDER MONKEY · 6/13/2013
AstraZeneca (LON: AZN)‘s stock had its “buy” rating reaffirmed by stock analysts at Shore Capital Stockbrokers in a report issued on Monday, ARN reports. Shares of AstraZeneca (LON: AZN) traded down 0.95% during mid-day trading on Monday …Zolmax News · 6/10/2013
This might insinuate that AstraZeneca is acquiring the company at a discount of 5.22%, as per Wednesday’s market price of $13.40 (12.53 p.m EDT), but that is not the case. The announcement just drove the stock to the rooftop, and now I fear that …beta.fool.com · 6/8/2013
AstraZeneca (LON: AZN)‘s stock had its “neutral” rating reiterated by analysts at JPMorgan Chase in a research report issued to clients and investors on Friday, Stock Ratings Network.com reports. They currently have a GBX 3,400 ($51.44) target price ...mideasttime.com · 5/27/2013
- © 2013 Microsoft |
- Privacy and Cookies |
- Legal |
- Advertise |
- About our ads |
- Help |
- Feedback